Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J. H. Shepherd

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 7, 2004
Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancerE C Brockbank, T E J Ind, D P J Barton, et al.
Gynecologic Oncology|September 1, 2006
Somatic mitochondrial DNA mutations in primary and metastatic ovarian cancerP O Van Trappen, T Cullup, R Troke, et al.
Cancer Research|September 1, 1987
Localization of radioiodine conjugated to the monoclonal antibody HMFG2 in human ovarian carcinoma: assessment of intravenous and intraperitoneal routes of administrationB G Ward, S J Mather, L R Hawkins, et al.
Radiology|August 3, 1999
Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experienceP D Peppercorn, A R Jeyarajah, R Woolas, et al.
Journal of Clinical Pathology|October 1, 1994
Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinomaP A van Dam, I B Vergote, D G Lowe, et al.
BMJ (Clinical Research Ed.)|February 2, 1991
Hormone replacement therapy and survival after surgery for ovarian cancerR A Eeles, S Tan, E Wiltshaw, et al.
European Journal of Nuclear Medicine|June 1, 1993
Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancerM Granowska, K E Britton, S J Mather, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 13, 2018
MRI measurement of residual cervical length after radical trachelectomy for cervical cancer and the risk of adverse pregnancy outcomes: a blinded imaging analysisR M Alvarez, I Biliatis, A Rockall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trialC J Williams, G M Mead, F R Macbeth, et al.
British Journal of Cancer|January 24, 2007
Molecular profiling of cervical cancer progressionT Hagemann, T Bozanovic, S Hooper, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 7, 2004
Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancerE C Brockbank, T E J Ind, D P J Barton, et al.
Gynecologic Oncology|September 1, 2006
Somatic mitochondrial DNA mutations in primary and metastatic ovarian cancerP O Van Trappen, T Cullup, R Troke, et al.
Cancer Research|September 1, 1987
Localization of radioiodine conjugated to the monoclonal antibody HMFG2 in human ovarian carcinoma: assessment of intravenous and intraperitoneal routes of administrationB G Ward, S J Mather, L R Hawkins, et al.
Radiology|August 3, 1999
Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experienceP D Peppercorn, A R Jeyarajah, R Woolas, et al.
Journal of Clinical Pathology|October 1, 1994
Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinomaP A van Dam, I B Vergote, D G Lowe, et al.
BMJ (Clinical Research Ed.)|February 2, 1991
Hormone replacement therapy and survival after surgery for ovarian cancerR A Eeles, S Tan, E Wiltshaw, et al.
European Journal of Nuclear Medicine|June 1, 1993
Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancerM Granowska, K E Britton, S J Mather, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 13, 2018
MRI measurement of residual cervical length after radical trachelectomy for cervical cancer and the risk of adverse pregnancy outcomes: a blinded imaging analysisR M Alvarez, I Biliatis, A Rockall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trialC J Williams, G M Mead, F R Macbeth, et al.
British Journal of Cancer|January 24, 2007
Molecular profiling of cervical cancer progressionT Hagemann, T Bozanovic, S Hooper, et al.
Pageof 11